Print
When Stephanie Fajuri, 36, had an abnormal Pap smear a decade ago, her doctor advised her to come in for annual screenings to keep an eye on her health. She was diligent about doing so regularly until she was confronted by a pandemic.
An appointment scheduled last summer was pushed to December, Fajuri said. By the time she finally saw a doctor, she had developed more abnormal cells and had to undergo a procedure to remove them from her cervix.
“Thankfully, I am vigilant about my health,” she said, “but this is how women develop cervical cancer.”
Like Fajuri, women across Southern California are reporting appointments delayed, exams canceled and screenings postponed because of the pandemic. Some are voluntarily opting out for fear of encountering the virus, while others have had their appointments canceled by healthcare providers rerouting resources to COVID-19 patients.
Another casualty of the pandemic? Women s health
msn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from msn.com Daily Mail and Mail on Sunday newspapers.
Just living with pain Women s healthcare suffers as pandemic interferes with access
msn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from msn.com Daily Mail and Mail on Sunday newspapers.
Skin cancer detection company Dermtech (NASDAQ:DMTK) has seen a spree of good news lately. The company is reimagining the way skin cancer is detected, using stickers rather than scalpels to remove cells for testing. With several factors pushing the stock to double so far this year, its ascent may be just beginning.
The clinical data for its melanoma detection sticker, which is called the Pigmented Lesion Assay (PLA), is promising, with the sticker demonstrating superiority to a traditional scalpel-wielding biopsy. Just how much better is it? Standard biopsies miss about 17% of melanoma cases; the PLA misses just 1%. It s also more efficient for every 25 biopsies performed, only one melanoma will be found, compared with one melanoma for every 2.7 PLA tests. All of this is a big win for patients but the positive news for this small cap doesn t stop there.